
Freddie Kirkland Iii
Examiner (ID: 290)
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2856 |
| Total Applications | 1942 |
| Issued Applications | 1671 |
| Pending Applications | 84 |
| Abandoned Applications | 212 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10987412
[patent_doc_number] => 20160184358
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2016-06-30
[patent_title] => 'BOWEL CLEANSING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/724931
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2320
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/724931 | BOWEL CLEANSING COMPOSITION | Dec 20, 2012 | Abandoned |
Array
(
[id] => 9175476
[patent_doc_number] => 20130317461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING ESTRADIOL IN TRANSDERMAL DRUG DELIVERY SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 13/715276
[patent_app_country] => US
[patent_app_date] => 2012-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9364
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13715276
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/715276 | Compositions and methods for delivering active agents in transdermal drug delivery systems | Dec 13, 2012 | Issued |
Array
(
[id] => 8900335
[patent_doc_number] => 20130167838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'NASAL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/708314
[patent_app_country] => US
[patent_app_date] => 2012-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4329
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708314
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/708314 | NASAL FORMULATION | Dec 6, 2012 | Abandoned |
Array
(
[id] => 9838585
[patent_doc_number] => 20150030666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'ADHESIVE SKIN PATCH'
[patent_app_type] => utility
[patent_app_number] => 14/360831
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17264
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360831
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/360831 | ADHESIVE SKIN PATCH | Nov 27, 2012 | Abandoned |
Array
(
[id] => 10919310
[patent_doc_number] => 20140322327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/358141
[patent_app_country] => US
[patent_app_date] => 2012-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16373
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358141 | Drug delivery system for sustained delivery of bioactive agents | Nov 14, 2012 | Issued |
Array
(
[id] => 8707588
[patent_doc_number] => 20130064877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL'
[patent_app_type] => utility
[patent_app_number] => 13/672057
[patent_app_country] => US
[patent_app_date] => 2012-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13041
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672057
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/672057 | COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL | Nov 7, 2012 | Abandoned |
Array
(
[id] => 9736084
[patent_doc_number] => 20140271796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 14/354151
[patent_app_country] => US
[patent_app_date] => 2012-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6206
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354151
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354151 | OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION | Oct 22, 2012 | Abandoned |
Array
(
[id] => 8779572
[patent_doc_number] => 20130101547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'THERMORESPONSIVE COMPOSITIONS FOR DERMATOLOGICAL USE AND METHODS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/653271
[patent_app_country] => US
[patent_app_date] => 2012-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40215
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13653271
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/653271 | THERMORESPONSIVE COMPOSITIONS FOR DERMATOLOGICAL USE AND METHODS THEREOF | Oct 15, 2012 | Abandoned |
Array
(
[id] => 9687001
[patent_doc_number] => 20140243765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/346031
[patent_app_country] => US
[patent_app_date] => 2012-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6868
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346031
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/346031 | PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF | Sep 20, 2012 | Abandoned |
Array
(
[id] => 10938962
[patent_doc_number] => 20140341983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'SMART™ SOLID ORAL DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/344221
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 17555
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344221
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344221 | SMARTâ„¢ SOLID ORAL DOSAGE FORMS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 9771283
[patent_doc_number] => 20140294947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'TAMPER RESISTANT IMMEDIATE RELEASE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/344271
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11968
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344271
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/344271 | TAMPER RESISTANT IMMEDIATE RELEASE FORMULATIONS | Sep 13, 2012 | Abandoned |
Array
(
[id] => 9615793
[patent_doc_number] => 20140205650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'COATED SUPPOSITORIES'
[patent_app_type] => utility
[patent_app_number] => 14/342931
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6637
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342931
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342931 | COATED SUPPOSITORIES | Sep 5, 2012 | Abandoned |
Array
(
[id] => 16381343
[patent_doc_number] => 10806149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method for producing silver-ion antibacterial liquid, silver-ion antibacterial liquid produced by said method, method for producing silver-ion antibacterial powder, and silver-ion antibacterial powder produced by said method
[patent_app_type] => utility
[patent_app_number] => 14/342210
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 9739
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342210
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342210 | Method for producing silver-ion antibacterial liquid, silver-ion antibacterial liquid produced by said method, method for producing silver-ion antibacterial powder, and silver-ion antibacterial powder produced by said method | Aug 30, 2012 | Issued |
Array
(
[id] => 14388251
[patent_doc_number] => 10307382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride
[patent_app_type] => utility
[patent_app_number] => 14/240810
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3534
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240810
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240810 | Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride | Aug 23, 2012 | Issued |
Array
(
[id] => 10925889
[patent_doc_number] => 20140328908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'CONTROLLED-RELEASE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/238961
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 33026
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238961
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238961 | Milrinone controlled-release formulation | Aug 15, 2012 | Issued |
Array
(
[id] => 8943783
[patent_doc_number] => 08496959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-30
[patent_title] => 'Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles'
[patent_app_type] => utility
[patent_app_number] => 13/584373
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 10982
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13584373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/584373 | Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles | Aug 12, 2012 | Issued |
Array
(
[id] => 9546849
[patent_doc_number] => 20140171497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/232691
[patent_app_country] => US
[patent_app_date] => 2012-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7780
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232691
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/232691 | ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR | Jul 25, 2012 | Abandoned |
Array
(
[id] => 8613025
[patent_doc_number] => 20130018337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'DERMAL DELIVERY DEVICE WITH IN SITU SEAL'
[patent_app_type] => utility
[patent_app_number] => 13/553362
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8353
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553362
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553362 | Dermal delivery device with in situ seal | Jul 18, 2012 | Issued |
Array
(
[id] => 8482914
[patent_doc_number] => 20120282321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering'
[patent_app_type] => utility
[patent_app_number] => 13/553248
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7922
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553248
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/553248 | Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering | Jul 18, 2012 | Abandoned |
Array
(
[id] => 8452834
[patent_doc_number] => 20120263780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same'
[patent_app_type] => utility
[patent_app_number] => 13/534028
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8059
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/534028 | Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same | Jun 26, 2012 | Abandoned |